News

Overweight Patients Don't Have Higher Risk of Death After Surgery


 

FROM THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF CHEST PHYSICIANS

HONOLULU – Having a higher body mass index is not significantly associated with hospital mortality among patients admitted to the surgical ICU.

While similar findings have been reported in medical ICUs, this is believed to be the largest study to investigate the relationship between BMI and mortality exclusively in a surgical ICU, Dr. Adam Khader said in an interview during a poster session at the annual meeting of the American College of Chest Physicians.

Dr. Adam Khader

Dr. Khader, a resident in the department of surgery at Hofstra North Shore–Long Island Jewish Medical Center, Manhasset, N.Y., and his associates evaluated the records of 1,860 patients admitted to the medical center’s surgical ICU. Patients younger than age 18 years and those who did not undergo surgery were excluded from the analysis. The researchers used area under the receiver operating characteristic curves to assess the effect of BMI on mortality and categorized patients as underweight (BMI less than 20 kg/m2), normal weight (20-25 kg/m2), overweight (25-30 kg/m2), obese (30-35 kg/m2), severely obese (35-50 kg/m2), and super obese (greater than 50 kg/m2).

Overall 30-day hospital mortality was 10%. Hospital mortality was 15% for underweight patients, 11% for normal weight patients, 8% for overweight patients, 9% for obese patients, 13% for severely obese patients, and 22% for super obese patients. Area under the receiver operating characteristic curve analysis yielded no significant association between BMI and mortality, even after stratification of patients by elective vs. emergent surgery, and patients younger vs. older than age 75 years.

Dr. Khader and his associates observed a trend toward increased mortality for patients in the underweight, obese, and severely obese categories of BMI, "but nothing statistically significant," he said. "Still, there was a large number of patients [in this study]. You can’t really ignore the numbers."

Dr. Khader said that he had no relevant financial conflicts to disclose.

Recommended Reading

Poor Outcomes Terminate Triple Therapy in IPF Trial
MDedge Internal Medicine
Hospital Stay for Nosocomial Pneumonia Shortened by Tapering Antibiotic
MDedge Internal Medicine
Sleep Apnea Worsens Psychiatric Symptoms
MDedge Internal Medicine
Adverse Effects Discourage Imatinib for Treatment of SSc
MDedge Internal Medicine
22 Years From One Cystic Fibrosis Breakthrough to Another
MDedge Internal Medicine
A Win for Big Tobacco
MDedge Internal Medicine
Steroids May Help if Given Early in ALI-ARDS
MDedge Internal Medicine
Most Smokers Want to Quit; Few Get Help
MDedge Internal Medicine
Fostering Meaningful Communication at Life's End
MDedge Internal Medicine
Criteria Shift for Lung Transplantation Candidacy
MDedge Internal Medicine